Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains-Reference-Cited by-同舟云学术

Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains

Published:2003-03-18 Issue:9 Volume:46 Page:1764-1768
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tamamura Hirokazu¹,Koh Yasuhiro¹,Ueda Satoshi¹,Sasaki Yoshikazu¹,Yamasaki Tomonori¹,Aoki Manabu¹,Maeda Kenji¹,Watai Yoriko¹,Arikuni Hisashi¹,Otaka Akira¹,Mitsuya Hiroaki¹,Fujii Nobutaka¹

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan; Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan; Yokohama Laboratory, SC BioSciences Corporation, Hodogaya-ku, Yokohama 240-0005, Japan; and Experimental Retrovirology Section, Medicine Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm020537i

Reference21 articles.

1. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogs with varying side chains: the "iminoacridan hypothesis"

2. Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic Mice

3. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

4. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical Oxidative Sulfonylation–Azidation of Alkenes;The Journal of Organic Chemistry;2024-04-25

2. Lanthanoids in Hydroarylaminations: Yb(III)- and Tb(III)-Catalyzed Addition of Arylamines to Activated Olefins;Synthesis;2024-03-06

3. Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement;Chemical and Pharmaceutical Bulletin;2023-12-01

4. Asymmetric Synthesis of α‐Difluorinated β‐Amino Sulfones through Detrifluoroacetylative Mannich Reactions;European Journal of Organic Chemistry;2021-06

5. The Chiron Approach to (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol, a Key Subunit of HIV-1 Protease Inhibitor Drug, Darunavir;The Journal of Organic Chemistry;2020-12-03